Global High Content Screening (HCS) Market 2015-2019


◆タイトル:Global High Content Screening (HCS) Market 2015-2019
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆資料形式:pdf / 英語
Single UserUSD2,500 ⇒換算¥272,500見積依頼/購入/質問フォーム
Five UserUSD3,000 ⇒換算¥327,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。



About HCS
High-content screening (HCS) technology involves imaging-based multi-parametric analysis at the single-cell level. This technology was initially developed to complement biological high throughput screening in drug discovery. HCS analyses phenotypic changes in cellular samples.

Technavio’s analysts forecast the global HCS market to grow at a CAGR of 11.53% over the period 2014-2019.

[Covered in this Report]
The report includes the present scenario and the growth prospects of the global HCS market for the period 2015-2019. The market can be segmented into three customer segments: Pharmaceutical and biotechnology companies, academia and research institutes, and contract research organizations.
Technavio’s report, Global HCS Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global HCS market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

[Key Regions]
• Americas

[Key Vendors]
• Becton, Dickinson and Company
• GE Healthcare
• Danaher
• PerkinElmer
• Thermo Fisher Scientific

[Other Prominent Vendors]
• Blue Sky Bioservices
• Cell Signaling Technology
• Charles River Laboratories International
• Cytoo
• EMD Millipore
• Evotec
• Fluofarma
• Genedata
• Imagen Biotech
• Thorlabs
• Tecan
• Vala Sciences
• Wako Automation
• Yokogawa

[Market Driver]
• Growing Importance of High Content Screening in Therapeutics
• For a full, detailed list, view our report

[Market Challenge]
• Handling Large Amount of Data
• For a full, detailed list, view our report

[Market Trend]
• Advances in Personalized Medicines
• For a full, detailed list, view our report

[Key Questions Answered in this Report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?


01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology


06.Key Developments

07.Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis

08.Market Segmentation by End-User

09.Geographical Segmentation
09.1 Segmentation of Global HCS Market by Region
09.2 HCS Market in Americas
09.2.1 Market Size and Forecast
09.3 HCS Market in EMEA
09.3.1 Market Size and Forecast
09.4 HCS Market in APAC
09.4.1 Market Size and Forecast

10.Buying Criteria

11.Market Drivers

12.Drivers and Their Impact

13.Market Challenges

14.Impact of Drivers and Challenges

15.Market Trends

16.Trends and Their Impact

17.Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2014
17.2.1 BD
17.2.2 GE Healthcare
17.2.3 Molecular Devices (Subsidiary of Danaher)
17.2.4 PerkinElmer
17.2.5 Thermo Fisher Scientific
17.3 Other Prominent Vendors

18.Key Vendor Analysis
18.1 Becton, Dickinson and Co.
18.1.1 Key Facts
18.1.2 Business Description
18.1.3 Business Segmentation
18.1.4 Revenue Segmentation by Business
18.1.5 Segmental Revenue Comparison 2013 and 2012
18.1.6 Revenue Segmentation by Region
18.1.7 Business Strategy
18.1.8 Key Developments
18.1.9 SWOT Analysis
18.2 GE Healthcare
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Business Segmentation
18.2.4 Business Strategy
18.2.5 Key Developments
18.2.6 SWOT Analysis
18.3 Danaher
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Business Segmentation
18.3.4 Revenue by Business Segmentation
18.3.5 Revenue Comparison 2012 and 2013
18.3.6 Segmentation by Region
18.3.7 Business Strategy
18.3.8 Key Information
18.3.9 SWOT Analysis
18.4 PerkinElmer
18.4.1 Key Facts
18.4.2 Business Description
18.4.3 Business Segmentation
18.4.4 Business Strategy
18.4.5 Revenue Segmentation by Business
18.4.6 Key Developments
18.4.7 SWOT Analysis
18.5 Thermo Fisher Scientific
18.5.1 Key Facts
18.5.2 Business Overview
18.5.3 Business Segmentation by Revenue 2014
18.5.4 Business Segmentation by Revenue 2013 and 2014
18.5.5 Geographical Segmentation by Revenue 2014
18.5.6 Business Strategy
18.5.7 Recent Developments
18.5.8 SWOT Analysis

19.Other Reports in This Series

[List of Exhibits]

Exhibit 1: Market Research Methodology
Exhibit 2: Advantages of HCS over Traditional Technologies
Exhibit 3: Global HCS Market 2014-2019 ($ millions)
Exhibit 4: Segmentation of Global HCS Market by End-User
Exhibit 5: Segmentation of Global HCS Market by End-User 2014
Exhibit 6: Segmentation of Global HCS Market by Region 2014
Exhibit 7: HCS Market in Americas 2014-2019 ($ millions)
Exhibit 8: HCS Market in EMEA 2014-2019 ($ millions)
Exhibit 9: HCS Market in APAC 2014-2019 ($ millions)
Exhibit 10: Pros and Cons of IN Cell Analyzer 2000
Exhibit 11: Pros and Cons of ImageXpress Micro Widefield (Standard) and Image Xpress Micro Widefield XL
Exhibit 12: Pros and Cons of Opera
Exhibit 13: Pros and Cons of Operetta
Exhibit 14: Product Categorization of Becton, Dickinson and Co.
Exhibit 15: Revenue Segmentation of Becton, Dickinson and Co. 2013
Exhibit 16: Revenue Comparison ($ millions)
Exhibit 17: Revenue Segmentation of Becton, Dickinson and Co. by Region 2013
Exhibit 18: GE Healthcare: Business Segmentation 2013
Exhibit 19: Danaher: Business Segmentation
Exhibit 20: Danaher: Business Segmentation 2013
Exhibit 21: Danaher: Revenue by Business Segmentation 2012 and 2013 ($ millions)
Exhibit 22: Danaher: Revenue by Geographical Segmentation 2013
Exhibit 23: PerkinElmer: Business Segmentation 2013
Exhibit 24: PerkinElmer: Revenue Segmentation 2013
Exhibit 25: PerkinElmer: Revenue by Business Segments 2013 and 2012 ($ billions)
Exhibit 26: Thermo Fisher Scientific: Business Segmentation by Revenue 2014
Exhibit 27: Thermo Fisher Scientific: Business Segmentation by Revenue 2013 and 2014 ($ billions)
Exhibit 28: Thermo Fisher Scientific: Geographical Segmentation by Revenue 2014


Becton, Dickinson and Company, GE Healthcare, Danaher, PerkinElmer, Thermo Fisher Scientific, Blue Sky Bioservices, Cell Signaling Technology, Charles River Laboratories International, Cytoo, EMD Millipore, Evotec, Fluofarma, Genedata, Imagen Biotech, Thorlabs, Tecan, Vala Sciences, Wako Automation, Yokogawa





★調査レポート[ハイコンテンツスクリーニング(HCS)の世界市場] (Global High Content Screening (HCS) Market 2015-2019 / IRTNTR6483)販売に関する免責事項
[ハイコンテンツスクリーニング(HCS)の世界市場] (Global High Content Screening (HCS) Market 2015-2019 / IRTNTR6483)についてEメールでお問い合わせ